Voloridge Investment Management
PRAX icon

Voloridge Investment Management’s Praxis Precision Medicines PRAX Stock Holding History

Voloridge Investment Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-116,062
Closed -$8.93M – 1329
2024
Q4 		$8.93M Buy
116,062
+40,875
+54% +$2.96M 0.03% 606
2024
Q3 		$4.33M Buy
75,187
+39,964
+113% +$2.16M 0.02% 812
2024
Q2 		$1.46M Buy
35,223
+7,556
+27% +$357K 0.01% 994
2024
Q1 		$1.69M Buy
+27,667
New +$1.24M 0.01% 885
2021
Q4 		– Sell
-770
Closed -$214K – 1792
2021
Q3 		$214K Sell
770
-2,117
-73% -$574K ﹤0.01% 1578
2021
Q2 		$792K Buy
+2,887
New +$1.03M 0.01% 1326

Other funds holding PRAX

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Voloridge Investment Management's PRAX Position: Q1 2025 in Review

Voloridge Investment Management sold out of Praxis Precision Medicines (PRAX) in Q1 2025, closing a stake of 116,062 shares — an estimated $8.93M sold.

Voloridge Investment Management first reported a position in PRAX in Q2 2021 and held it in 6 quarters. The position peaked at $8.93M in Q4 2024. 150 funds tracked by Wall St. Rank hold PRAX as of Q1 2025.

  • Voloridge Investment Management reported no remaining Praxis Precision Medicines position as of Q1 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 116,062 Praxis Precision Medicines shares in Q1 2025, an estimated $8.93M.
  • Voloridge Investment Management first reported a position in Praxis Precision Medicines in Q2 2021 and held it in 6 quarters.
  • Voloridge Investment Management's Praxis Precision Medicines position peaked at $8.93M in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.